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Background: In this multi-country cluster-randomized behavioural intervention trial promoting exclusive
breastfeeding (EBF) in Africa, we compared growth of infants up to 6 months of age living in communities
where peer counsellors promoted EBF with growth in those infants living in control communities.
Methods: A total of 82 clusters in Burkina Faso, Uganda and South Africa were randomised to either the
intervention or the control arm. Feeding data and anthropometric measurements were collected at visits scheduled
3, 6, 12 and 24 weeks post-partum. We calculated weight-for-length (WLZ), length-for-age (LAZ) and weight-for-age
(WAZ) z-scores. Country specific adjusted Least Squares Means with 95% confidence intervals (CI) based on a
longitudinal analysis are reported. Prevalence ratios (PR) for the association between peer counselling for EBF and
wasting (WLZ < −2), stunting (LAZ < −2) and underweight (WAZ < −2) were calculated at each data collection point.
Results: The study included a total of 2,579 children. Adjusting for socio-economic status, the mean WLZ at
24 weeks were in Burkina Faso −0.20 (95% CI −0.39 to −0.01) and in Uganda −0.23 (95% CI −0.43 to −0.03) lower in
the intervention than in the control arm. In South Africa the mean WLZ at 24 weeks was 0.23 (95% CI 0.03 to 0.43)
greater in the intervention than in the control arm. Differences in LAZ between the study arms were small and not
statistically significant. In Uganda, infants in the intervention arm were more likely to be wasted compared to those
in the control arm at 24 weeks (PR 2.36; 95% CI 1.11 to 5.00). Differences in wasting in South Africa and Burkina Faso
and stunting and underweight in all three countries were small and not significantly different.
Conclusions: There were small differences in mean anthropometric indicators between the intervention and
control arms in the study, but in Uganda and Burkina Faso, a tendency to slightly lower ponderal growth
(weight-for-length z-scores) was found in the intervention arms.
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The World Health Organization (WHO) has since 2001
recommended exclusive breastfeeding (EBF) for the
first six months of life [1]. It is estimated that universal
coverage with general nutritional interventions including
exclusive breastfeeding promotion could prevent 8% of
child deaths under the age of 36 months and 10-15% of
stunting [2]. The systematic reviews by Kramer et al.
reported that EBF for 6 months compared to EBF for 3 to
4 months resulted in lower diarrheal morbidity, prolonged
lactational amenorrhoea and no clear infant growth deficit
among infants in either low- or high income countries
[3,4]. However, few African studies were included in that
review and the authors stated that “larger sample sizes
would be required to rule out modest increases in the risk
of undernutrition” with longer duration than 3–4 months
of EBF [3,5].
A recent systematic review reported that peer support
for breastfeeding decreased the risk of non-exclusive
breastfeeding at last study-follow-up by 37% in low- and
middle income countries compared to only 10% in high
income countries [4]. Even if breastfeeding promotion
can substantially increase the proportion of infants that
are breastfed [6,7], its effect on growth is less clear. It is
assumed that breastfed infants are healthier than non-
breastfed infants [2,8,9]. This is expected to result from
reduced incidence and severity of communicable diseases,
including diarrhoea [6,8] and improved feeding during
illness [6,9,10]. Other expected benefits are lower risk of
autoimmune diseases [11] and potential long term bene-
ficial effects including on cognition [12-15]. In addition,
formula fed infants may receive excess energy, which
could lead to overweight in childhood, and potentially
later in life [10,16,17].
This cluster-randomised trial estimated the effect of
community-based promotion of EBF by peer counsellors
on the prevalence of EBF and diarrhea [18]. In order to
address whether EBF promotion could impact infant
growth, this paper reports on growth patterns including
ponderal growth (expressed as weight-for-length z-scores)
and linear growth (length-for-age z-scores) as well as
weight-for-age z-scores up to 6 months of age in children
participating in the PROMISE EBF trial in Burkina Faso,
Uganda and South Africa. Our research question was
whether there was any significant difference in growth
patterns between the intervention and control clusters by
24 weeks of age.
Methods
The effect of peer counselling on EBF and diarrhoea
prevalence and the methods used in the PROMISE EBF
trial are described elsewhere [18]. Briefly, the study was
conducted in three countries: Burkina Faso, Uganda and
South Africa. In Burkina Faso, the study was conductedin Banfora, a south-western rural area dominated by
subsistence farming. In Uganda, the sites comprised
rural Bungokho in Mbale District where both subsist-
ence farming and petty trading are common, and urban
Mbale Municipality characterised by informal settlements
and small industries. There were three geographically sep-
arate sites in South Africa: 1) Paarl, a commercial farming
area in the Western Cape Province, 2) peri-urban Umlazi,
and 3) rural Rietvlei in KwaZulu-Natal. Infant mortality
rates (IMRs) at the time of the study were 92/1,000 in
Burkina Faso and 85/1,000 in Uganda. In South Africa,
the IMRs were 40/1,000 in Paarl, 60/1,000 in Umlazi and
99/1,000 in Rietvlei [19].
Within each country and site, clusters were randomised
1:1 to either the intervention (provision of EBF peer-
counselling) or the control arm (where EBF was not pro-
moted by our research team) [18]. This was also the case
in South Africa, and in addition a separate team of peer
supporters supported the families to obtain birth certifi-
cates and social welfare grants in the control clusters [20].
This was believed not to interfere with breastfeeding
behaviour. Clusters were selected geographically to reduce
contamination of the intervention.
The intervention consisted of EBF counselling by peer-
counsellors that were from the local communities and
trained in a one week course by the national research
teams with a curriculum adapted from the WHO courses
‘Breastfeeding Counselling: a Training Course’ [21] and ‘HIV
& Infant Feeding Counselling: a Training Course’ [22]. All
mothers were offered at least five home visits, the first
occurred in the third trimester of pregnancy. Qualitative
descriptions of the intervention are given elsewhere [23-25].
Sample size calculation was done for EBF and diarrhea
prevalence [18]. Those intending to breastfeed and plan-
ning to stay in the selected cluster in the forthcoming
year were included, further details on recruitment, inclu-
sion and exclusion are given in the Additional file 1. The
analysis included 2,579 singleton live children. The trial
profile is given in Figure 1.
Data were collected between 2006 and 2008 using a
recruitment interview late in pregnancy, and further
interviews targeted at weeks 3, 6, 12 and 24 after birth.
Structured questionnaires were developed and adapted
from the literature [26,27] and informed by prior work
in the participating countries [28-30]. The first recruit-
ment interview focused mainly on socio-demographic and
socio-economic characteristics. The follow-up contact
points captured mother-reported feeding practices and
infant illness, and the children’s length and weight were
recorded. Interviews were regarded as ‘timely’ if they were
done within the following time periods: 1.5–4.5 (3); 4.5–9
(6); 9–18 (12); and 18–28 (24) weeks. Timely measure-
ments provided data for the undernutrition prevalence
estimates. The trial profile reflects number of ‘timely’ out
Figure 1 Promise EBF trial profile in Burkina Faso, Uganda and South Africa.
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profile also reflects the number of anthropometric mea-
surements, all measurements went into the longitudinal
modelling of the anthropometric data.
Length was measured to the nearest 0.1 cm using ‘Shorr
Height-Length Measuring Board’ (Maryland, USA) pro-
vided as ‘Baby/infant/adult Length-height measuring sys-
tem SET 2’ from UNICEF in Uganda, and ‘Seca 210
mobile measuring mats for babies and toddlers,’ with
0.5 cm precision, in Burkina Faso and TALC’s roller mat
infantometer (Oxford, UK) in South Africa. Infant weight
was recorded to the nearest 0.1 kg using the ‘Infant scale
spring type, 25 kg, 100 g’ from UNICEF in Uganda, the
‘SECA 872 scale with mother-infant children’s’ function’
in Burkina Faso and ‘Mascott electronic bucket’ in South
Africa. The measurement procedures followed standard
WHO guidelines [31]. All data collectors underwent train-
ing in content, questionnaire techniques and measure-
ments and were kept uninformed about cluster allocation.
For the weight and length measurements, reproducibility
and validity exercises were conducted. Re-training and
evaluation were done at least semi-annually during thedata collection period. The acceptable technical error of
measurement (TEM) for a data collector [32] was a value
less than two times that of the data collector supervisor, a
clinical specialist.
Definitions
A strict definition of exclusively breastfeeding (EBF) was
applied. Infants were classified as EBF if they did not
receive food or liquids other than breast milk except for
medicines using a 24-hour and 7-day recall at 12 and
24 weeks of age [18]. WHO Child Growth Standards
(2006) were used to estimate anthropometric status [33]:
weight-for-length z-scores (WLZ), length-for-age z-scores
(LAZ) and weight-for-age z-scores (WAZ). Children who
had WLZ below −2 (WLZ < −2) were considered wasted,
those with LAZ below −2 (LAZ < −2) stunted, and those
with WAZ below −2 (WAZ < −2) underweight. Attri-
bution of socio-economic status was based on within
country ranking of groupings of different household com-
modities as variables in a multiple correspondence ana-
lysis, a technique which is suitable for categorical variables
and similar to principal component analysis [34].
Table 1 Baseline characteristics of participants in the
intervention arm and the control arm in each of the 3
countries, presents continuous data presented
Intervensjon n Control
n Mean (SD) n Mean (SD)
Maternal age in years
Burkina Faso 292 25.8 (6.5) 318 25.8 (6.6)
Uganda 393 25.8 (6.8) 363 25.6 (6.5)
South Africa 533 24.4 (6.3) 485 24.2 (6.1)
Maternal education in years
Burkina Faso 377 0.8 (1.9) 379 0.7 (1.9)
Uganda 391 6.1 (3.1) 365 6.5 (3.5)
South Africa 535 10.1 (2.3) 485 10.0 (2.3)
Maternal BMI
Burkina Faso 247 21.0 (2.0 214 21.9 (2.4)
Uganda 343 22.2 (2.9) 312 22.2 (2.7)
South Africa 432 26.8 (6.2) 398 26.4 (5.7)
Birth weight, kg*
Burkina Faso 7 3.4 (0.8) 6 3.2 (0.8)
Uganda 127 3.3 (0.6) 142 3.4 (0.7)
South Africa 495 3.2 (0.5) 446 3.1 (0.5)
*The data are reported from health cards if measurements were taken by
health staff and recordings available and illustrate very limited use of health
facilities in Burkina Faso and also low use in Uganda. The PROMISE EBF team
had no influence on the quality of the birth weight measurements.
Engebretsen et al. BMC Public Health 2014, 14:633 Page 4 of 12
http://www.biomedcentral.com/1471-2458/14/633Data handling and analysis
Descriptive statistics included means with 95% confidence
intervals, medians and ranges for continuous variables
and prevalence estimates with 95% confidence intervals
for categorical variables. The data were analysed using
STATA SE11.0 (Stata Corp LP, College Station, TX, USA)
and SAS V9.2 (SAS Institute Inc., Cary, NC, USA).
Missed visits, the fact that some mothers did not con-
sent to measurements at all visits, and the data cleaning
process resulted in some missing anthropometric data.
A detailed description of data cleaning and handling of
missing anthropometric information is presented in the
Additional file 1. An inverse-probability weighted method
(IPW) was used instead of a plain available-subject-analysis
to adjust for potential differences in follow-up between
groups (Additional file 1).
Analysis was done by country and estimates took into
account the design effect for having randomized clusters
rather than individuals; for Uganda and South Africa we
also adjusted for site. For the categorical anthropometric
outcomes, generalised linear models (binomial family
with a log link) were used to calculate prevalence ratios
(PR). In the longitudinal analysis, the correlated nature
of the data from the repeated measurements was taken
into account by adjusting for repeated measurements in
the same individual as well as the above-mentioned
design effect resulting from the cluster randomization. A
linear mixed effects regression model (PROC MIXED in
SAS) was used in the longitudinal analysis of z-scores
with cluster as a random effect and the repeated measure-
ments in each child accounted for through a first order
autocorrelation structure. Least Squares Means (LSM),
which are analogous to estimated marginal means, are
reported at 3, 6, 12 and 24 weeks, corresponding to the
scheduled data collection visits. This paper presents the
growth data in line with the trial design (intention-to-
treat), and is not restricted to those mother-infant pairs
who actually received per counselling and the frequency
or duration of counselling is not considered in the models.
Acknowledging that socio-economic status can affect
growth [35], we also present data adjusted for socio-
economic status. The study team planned to present the
growth data by country acknowledging the large country
differences in socio-economic status, feeding and health
related factors [18].
Ethical approval
Approval for the trial (ClinicalTrials.gov: NCT00397150)
was obtained from the following bodies: 1) Burkina Faso:
the Institutional Review board of Centre Muraz (No
013/2005/CE-CM) and from the Ministry of Health at
national and regional level; 2) Uganda: Makerere
University Faculty of Medicine Research and Ethics Com-
mittee, and the Uganda National Council for Science andTechnology; 3) South Africa: Ethics Committee of the
Medical Research Council South Africa; and 4) Norway:
Regional Committees for Medical and Health Research
Ethics (REK VEST), 8 Sept 2005, issue number 05/8197.
Women provided verbal informed consent for partici-
pation in the peer-counselling programme, which was
regarded as a service. Written informed consent for




There were substantial baseline differences between the
three countries (Tables 1 and 2). Considering factors
such as years of schooling, electricity and socio-economic
status, participants in Burkina Faso were the poorest and
those in South Africa were least poor: 85% of women in
Burkina Faso had no education, compared to 7% in
Uganda and < 1% in South Africa. The same country dif-
ferences were also seen for maternal body size. Further, in
Uganda, participants were somewhat poorer in the inter-
vention arm than in the control arm. The effect of the
intervention on absolute change in EBF prevalence varied
substantially between countries. The largest effect was
seen in Burkina Faso and Uganda. Around 12 weeks, the
following differences in EBF prevalence according to a
Table 2 Baseline characteristics of participants in the
intervention arm and the control arm in each of the 3
countries, categorical data presented
Intervention Control
n (%) n (%)
Two upper socio-economic quintiles
Burkina Faso 157/392 (40.1) 158/401 (39.4)
Uganda 132/396 (33.3) 172/369 (46.6)
South Africa 221/535 (41.3) 213/485 (43.9)
Having access to toilet facility
Burkina Faso 3/168 (1.8) 3/232 (1.3)
Uganda 255/339 (75.2) 269/328 (82.0)
South Africa 433/515 (84.1) 389/456 (85.3)
Having electricity
Burkina Faso 18/389 (4.6) 5/402 (1.2)
Uganda 53/391 (13.6) 70/361 (19.4)
South Africa 409/535 (76.5) 445/485 (91.8)
Having access to non-surface water
Burkina Faso 271/388 (69.9) 239/400 (59.8)
Uganda 256/392 (65.3) 266/363 (73.3)
South Africa 414/535 (77.4) 379/484 (78.3)
Attended antenatal clinic
Burkina Faso 284/389 (73.0) 285/401 (71.1)
Uganda 272/376 (72.3) 274/352 (77.8)
South Africa 527/532 (99.1) 470/481 (97.7)
Delivery in health facility
Burkina Faso 143/372 (38.4) 128/370 (34.6)
Uganda 173/381 (45.4) 205/351 (58.4)
South Africa 486/514 (94.6) 423/461 (91.8)
Female infant
Burkina Faso 188/392 (48.0) 199/401 (49.6)
Uganda 194/394 (49.2) 181/368 (49.2)
South Africa 256/531 (48.2) 256/479 (53.4)
Having siblings
Burkina Faso 327/391 (83.6) 337/402 (83.8)
Uganda 311/392 (79.3) 281/366 (76.8)
South Africa 274/535 (51.2) 238/485 (49.1)
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tion and the control groups were observed in the three
countries: Burkina Faso: 79% versus 35%; Uganda: 82%
versus 44%; and South Africa: 10% versus 6% [18].
Ponderal growth
A statistically significant adjusted difference between
the arms was observed for WLZ in Burkina Faso at
12 weeks (Table 3). This difference was also present at
24 weeks when the mean WLZ (95% confidence intervals)was −0.74 (−0.87 to −0.60) in the intervention arm com-
pared to −0.53 (−0.67 to −0.40) in the control arm: an
adjusted difference of −0.20 (−0.39 to −0.01). In Uganda
the corresponding estimates were 0.03 (−0.12 to 0.17) in
the intervention arm compared to 0.28 (0.13 to 0.43)
in the control arm: an adjusted difference of −0.23
(−0.43 to −0.03). In South Africa, on the other hand,
the adjusted mean WLZ was 0.23 (0.03 to 0.43)
higher in the intervention than in the control arm at
24 weeks.
At the 12 week assessment, wasting was almost twice
as common in the intervention compared to in the
control arms in both Burkina Faso and Uganda (Table 4).
Adjusted prevalence ratios were 1.86 (1.09 to 3.19) in
Burkina Faso and 1.98 (0.99 to 3.93) in Uganda. At the
24 week assessment the corresponding estimates were
1.40 (CI 0.84 to 2.32) in Burkina Faso, and 2.36 (1.11 to
5.00) in Uganda. There were no statistically significant
differences in wasting prevalence in South Africa at 12
and 24 weeks.
Linear growth
The differences in mean LAZ between the intervention
and control arms were small (<0.15) and not statistically
significant (Table 3). No statistically significant differ-
ences were seen in the prevalence estimates for stunting
between arms in any of the countries at any of the visits
(Table 4).
Weight-for-age z-scores, underweight and weight change
In Uganda, the mean WAZ was lower in the interven-
tion arm than in the control arm: an adjusted difference
of −0.26 (−0.44 to −0.08) at 24 weeks (Table 3). The
adjusted difference in mean weight in grams (95% CI) at
24 weeks in Uganda was -211 g (−332 to −9) while in
Burkina Faso it was -97 g (−215 to 21). There were no
statistically significant differences observed in the preva-
lence estimates for underweight between arms in any of
the countries at any of the visits (Table 4).
Standard deviations
The standard deviations for WLZ ranged from 1.2 to 1.3
and that for LAZ from 1.2 to 1.5 over the scheduled
visits in the 3 countries (Additional file 1).
Discussion
This paper presents growth patterns including ponderal
and linear growth and weight information of children up
to six months of age who participated in a community-
based trial assessing promotion of EBF by peer counsellors
in Burkina Faso, Uganda and South Africa. Although the
reported EBF prevalence doubled at 12 weeks in the inter-
vention arms in all three countries, the absolute increase
was large in Burkina Faso and Uganda (44 and 38
Table 3 Weight-for-length (WLZ), weight-for-age (WAZ) and length-for-age (LAZ) least squares means (Mean) z-scores
at 3, 6, 12 and 24 weeks from longitudinal data analysis
Intervention Control Crudea Adjustedb
Mean (95% CI) Mean (95% CI) Difference (95% CI) Difference (95% CI)
WLZ
3 weeks
Burkina Faso −0.76 (−0.90;-0.62) −0.80 (−0.94;-0.66) 0.04 (−0.16;0.23) 0.04 (−0.16;0.24)
Uganda −0.08 (−0.23;-0.06) 0.01 (−0.14;0.16) −0.09 (−0.29;0.11) −0.07 (−0.27;0.13)
South Africa 0.54 (0.38;0.70) 0.58 (0.41;0.75) −0.04 (−0.27;0.19) −0.02 (−0.25;0.21)
6 weeks
Burkina Faso −0.64 (−0.77;-0.52) −0.56 (−0.68;-0.44) −0.09 (−0.26;0.09) −0.08 (−0.26;0.09)
Uganda 0.05 (−0.07;0.17) 0.13 (<0.01;0.26) −0.08 (−0.25;0.08) −0.06 (−0.23;0.10)
South Africa 0.61 (0.48;0.74) 0.56 (0.42;0.70) 0.05 (−0.13;0.23) 0.07 (−0.12;0.25)
12 weeks
Burkina Faso −0.52 (−0.65;-0.39) −0.28 (−0.40;-0.15) −0.24* (−0.42;-0.07) −0.24* (−0.42;-0.06)
Uganda 0.20 (0.07;0.33) 0.29 (0.16;0.43) −0.09 (−0.27;0.08) −0.07 (−0.25;0.11)
South Africa 0.69 (0.56;0.82) 0.52 (0.37;0.66) 0.17 (−0.01;0.36) 0.19* (0.01;0.38)
24 weeks
Burkina Faso −0.74 (−0.87;-0.60) −0.53 (−0.67;-0.40) −0.21* (−0.40;-0.01) −0.20* (−0.39;-0.01)
Uganda 0.03 (−0.12;0.17) 0.28 (0.13;0.43) −0.25* (−0.45;-0.06) −0.23* (−0.43;-0.03)
South Africa 0.62 (0.48;0.76) 0.41 (0.26;0.56) 0.21* (0.01;0.41) 0.23* (0.03;0.43)
LAZ
3 weeks
Burkina Faso −0.65 (−0.79;-0.52) −0.63 (−0.76;-0.49) −0.03 (−0.22;0.16) −0.03 (−0.21;0.15)
Uganda −0.32 (−0.45;-0.18) −0.21 (−0.35;-0.06) −0.11 (−0.30;0.08) −0.09 (−0.28;0.11)
South Africa −0.87 (−1.03;-0.71) −0.83 (−1.00;-0.65) −0.04 (−0.27;0.19) −0.06 (−0.29;0.18)
6 weeks
Burkina Faso −0.58 (−0.71;-0.46) −0.62 (−0.75;-0.50) 0.04 (−0.13;0.22) 0.04 (−0.13;0.21)
Uganda −0.35 (−0.48;-0.22) −0.21 (−0.34;-0.07) −0.14 (−0.32;0.03) −0.11 (−0.30;0.07)
South Africa −0.71 (−0.85;-0.57) −0.68 (−0.83;-0.53) −0.03 (−0.23;0.17) −0.04 (−0.25;0.16)
12 weeks
Burkina Faso −0.54 (−0.67;-0.42) −0.66 (−0.78;-0.53) 0.11 (−0.07;0.29) 0.12 (−0.06;0.30)
Uganda −0.45 (−0.58;-0.31) −0.26 (−0.41;-0.12) −0.18 (−0.37;0.002) −0.15 (−0.34;0.04)
South Africa −0.46 (−0.61;-0.31) −0.43 (−0.58;-0.27) −0.03 (−0.24;0.18) −0.04 (−0.25;0.18)
24 weeks
Burkina Faso −0.87 (−1.00;-0.74) −0.85 (−0.98;-0.72) −0.02 (−0.20;0.17) −0.02 (−0.20;0.16)
Uganda −0.78 (−0.93;-0.63) −0.61 (−0.77;-0.46) −0.17 (−0.37;0.04) −0.13 (−0.33;0.06)
South Africa −0.23 (−0.38;-0.08) −0.08 (−0.23;0.07) −0.15 (−0.36;0.06) −0.13 (−0.34;0.08)
WAZ
3 weeks
Burkina Faso −0.94 (−1.07;-0.81) −0.94 (−1.07;-0.82) 0.0 (−0.18;0.18) 0.0 (−0.18;0.18)
Uganda −0.26 (−0.39;-0.13) −0.09 (−0.23;0.04) −0.17 (−0.34;0.01) −0.14 (−0.33;0.05)
South Africa −0.33 (−0.46;-0.19) −0.26 (−0.41;-0.12) −0.06 (−0.26;0.14) −0.05 (−0.25;0.15)
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Table 3 Weight-for-length (WLZ), weight-for-age (WAZ) and length-for-age (LAZ) least squares means (Mean) z-scores
at 3, 6, 12 and 24 weeks from longitudinal data analysis (Continued)
6 weeks
Burkina Faso −0.90 (−1.02;-0.78) −0.87 (−0.99;-0.76) −0.03 (−0.20;0.15) −0.03 (−0.20;0.15)
Uganda −0.26 (−0.39;-0.14) −0.08 (−0.21;0.04) −0.18 (−0.34;0.02) −0.15 (−0.32;0.03)
South Africa −0.19 (−0.32;-0.06) −0.19 (−0.33;0.05) 0.0 (−0.18;0.19) 0.01 (−0.17;0.20)
12 weeks
Burkina Faso −0.89 (−1.01;-0.76) −0.82 (−0.94;-0.69) −0.07 (−0.25;0.10) −0.07 (−0.25;0.10)
Uganda −0.31 (−0.44;-0.18) −0.09 (−0.23;0.04) −0.21* (−0.39;-0.04) −0.18 (−0.36;0.01)
South Africa 0.03 (−0.10;0.16) −0.06 (−0.20;0.08) 0.09 (−0.10;0.28) 0.10 (−0.09;0.29)
24 weeks
Burkina Faso −1.15 (−1.29;-1.02) −1.01 (−1.14;-0.87) −0.15 (−0.34;0.04) −0.15 (−0.34;0.05)
Uganda −0.55 (−0.70;-0.41) −0.25 (−0.41;-0.09) −0.30* (-0.51;-0.10) −0.26* (-0.44;-0.08)
South Africa 0.22 (0.07;0.36) 0.14 (−0.02;0.30) 0.08 (−0.14;0.29) 0.09 (−0.13 to 0.30)
aControlled for clusters and repeated measurements from same individual.
bControlled for as aand adjusted for socio-economic status.
*p < 0.05.
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http://www.biomedcentral.com/1471-2458/14/633percentage points, respectively) and small in South Africa
(4 percentage points) [18]. The child growth patterns
varied in the three countries, with South Africa having the
highest z-scores on average and Burkina Faso having the
lowest. Ponderal growth tended to be slightly lower in
Burkina Faso and Uganda in the intervention arms com-
pared to the control arm even if the absolute weight dif-
ferences were quite small at 24 weeks, around 100 g and
statistically not significant in Burkina Faso, and around
200 g in Uganda at six months. Wasting was also more
common at 24 weeks of age in Uganda. No significant
differences were found for LAZ-scores between children
in the intervention and control arms.
Compared to individual randomisation, cluster random-
isation is more vulnerable to suboptimal randomisation as
fewer units are randomised, and there is a chance that
particular characteristics may be clustered [36]. However,
the intra-cluster coefficients for the main outcomes were
small [18]. Residual confounding from factors which we
were not able to assess is still possible; for instance, as
many of the births took place at home, gestational age and
birth weight were available only for a small proportion of
the mother-infant pairs in Burkina Faso and Uganda.
Some would argue that our anthropometric measure-
ments at around 3 weeks could act as a proxy for the
corresponding baseline characteristics. However, there
were only small differences in WLZ at 3 weeks of age and
adjusting for 3 week weight (data not shown) did not
substantially alter our effect estimates. It is known that
societal, maternal and individual factors are related to
growth outcomes [35,37,38], and some of these may have
been unmeasured and unevenly distributed between the
study arms. However, adjusting for socio-economic status,
which is likely to capture some of these characteristics,only minimally altered our effect measures. Missing data
were most common at 3 weeks because many mothers left
their homes and stayed with their relatives for some time
after giving birth. An inverse-probability weighted method
yielded similar results compared to an available-subject
analysis (data not shown) indicating no noteworthy bias
from missing data [39].
There were major country differences with regard to
the effect of the intervention on EBF prevalence [18],
and as reported in this paper, socio-economy, maternal
education and BMI as well as in infant growth patterns.
There were also country differences with respect to peri-
natal mortality [40-42]. Thus, we find it most appropri-
ate to present the results by country although pooling
the data would have increased our statistical precision.
As the absolute difference in EBF prevalence between
the arms in South Africa was very small, it is difficult to
attribute any differences in growth patterns to the EBF
promotion. The country specific contextual challenges
explaining this low uptake of EBF has been described
[43] as well as poor breastfeeding practices [44]. The
peer support for families to obtain a social welfare grant
provided in the control clusters is also unlikely to have
mitigated child growth.
The infants in the Multicentre Growth Reference
Study (MGRS) study [45], which yielded the reference
against which our infants’ growth was assessed, had non-
smoking mothers from middle class or ‘affluent’ environ-
ments supportive of healthy growth [46]. In that study,
75% were exclusively or predominantly breastfed for
4 months and nearly 70% breastfed for a year. In our
study, children from both Burkina Faso and Uganda were
at 12 weeks of age exclusively breastfed to the same or
even to a higher extent. The children in the PROMISE
Table 4 Wasting (WLZ < −2), underweight (WAZ < −2) and stunting (LAZ < −2) comparing the intervention and control
arm and prevalence ratios (PR)
Intervention Control Crudea Adjustedb
n (%) n (%) PR (95% CI) PR (95% CI)
Wasting
3 week
Burkina Faso 48/330 (14.55) 59/335 (17.61) 0.77 (0.44-1.32) 0.76 (0.45-1.29)
Uganda 15/280 (5.36) 14/265 (5.28) 0.90 (0.44-1.84) 0.96 (0.47-1.95)
South Africa 18/298 (6.04) 2/247 (0.81) 7.66‡ (2.30-25.49) 7.54‡ (2.17-26.25)
6 week
Burkina Faso 35/348 (10.06) 37/353 (10.48) 0.98 (0.53-1.78) 0.96 (0.53-1.71)
Uganda 12/331 (3.63) 8/293 (2.73) 1.36 (0.62-2.99) 1.25 (0.59-2.67)
South Africa 6/387 (1.55) 7/344 (2.03) 0.80 (0.28-2.23) 0.79 (0.25-2.45)
12 week
Burkina Faso 39/357 (10.92) 22/365 (6.03) 1.89* (1.08-3.29) 1.86* (1.09-3.19)
Uganda 22/361 (6.09) 10/316 (3.16) 2.04* (1.04-4.01) 1.98 (0.99-3.93)
South Africa 11/434 (2.53) 12/394 (3.05) 0.93 (0.46-1.87) 0.84 (0.42-1.69)
24 week
Burkina Faso 47/353 (13.3) 37/361 (10.2) 1.41 (0.82-2.45) 1.40 (0.84-2.32)
Uganda 26/344 (7.56) 10/316 (3.16) 2.39* (1.09-5.24) 2.36* (1.11-5.00)
South Africa 8/351 (2.28) 6/302 (1.99) 1.28 (0.34-4.75) 1.12 (0.30-4.11)
Stunting
3 week
Burkina Faso 39/333 (11.71) 42/340 (12.35) 0.90 (0.58-1.38) 0.89 (0.57-1.41)
Uganda 33/283 (11.66) 18/265 (6.79) 1.75 (0.86-3.56) 1.67 (0.85-3.31)
South Africa 45/301 (14.95) 49/248 (19.76) 0.77 (0.58-1.03) 0.78 (0.59-1.04)
6 week
Burkina Faso 37/349 (10.60) 40/356 (11.24) 0.91 (0.60-1.39) 0.90 (0.60-1.38)
Uganda 36/334 (10.78) 20/296 (6.76) 1.55 (0.89-2.71) 1.45 (0.87-2.40)
South Africa 61/387 (15.76) 52/346 (15.03) 1.17 (0.84-1.62) 1.19 (0.86-1.65)
12 week
Burkina Faso 46/358 (12.85) 51/366 (13.93) 0.81 (0.55-1.20) 0.81 (0.55-1.20)
Uganda 49/364 (13.46) 29/316 (9.18) 1.57 (0.86-2.86) 1.46 (0.80-2.67)
South Africa 62/435 (14.25) 59/395 (14.94) 0.97 (0.68-1.39) 0.96 (0.66-1.41)
24 week
Burkina Faso 59/353 (16.71) 57/361 (15.79) 1.08 (0.73-1.61) 1.07 (0.73-1.57)
Uganda 71/344 (20.64) 48/316 (15.19) 1.39 (0.93-2.08) 1.28 (0.86-1.90)
South Africa 42/352 (11.93) 33/303 (10.89) 1.11 (0.70-1.75) 1.07 (0.70-1.65)
Underweight
3 week
Burkina Faso 53/341 (15.54) 48/341 (14.08) 1.04 (0.65-1.65) 1.03 (0.64-1.64)
Uganda 22/285 (7.72) 14/268 (5.22) 1.50 (0.70-3.20) 1.30 (0.64-2.61)
South Africa 22/310 (7.10) 18/262 (6.87) 1.08 (0.62-1.89) 1.08 (0.62-1.90)
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Table 4 Wasting (WLZ < −2), underweight (WAZ < −2) and stunting (LAZ < −2) comparing the intervention and control
arm and prevalence ratios (PR) (Continued)
6 week
Burkina Faso 59/351 (16.81) 58/358 (16.20) 1.11 (0.71-1.75) 1.10 (0.71-1.71)
Uganda 23/333 (6.91) 12/293 (4.10) 1.52 (0.70-3.30) 1.44 (0.67-3.08)
South Africa 26/395 (6.58) 29/351 (8.26) 0.81 (0.46-1.40) 0.84 (0.47-1.47)
12 week
Burkina Faso 58/357 (16.25) 49/365 (13.42) 1.09 (0.73-1.61) 1.09 (0.74-1.59)
Uganda 37/361 (10.25) 17/316 (5.38) 2.04 (0.98-2.24) 1.80 (0.92-3.52)
South Africa 26/435 (5.98) 32/396 (8.08) 0.79 (0.49-1.29) 0.77 (0.48-1.24)
24 week
Burkina Faso 75/354 (21.19) 64/361 (17.73) 1.23 (0.88-1.72) 1.23 (0.88-1.71)
Uganda 56/345 (16.23) 32/317 (10.09) 1.67 (0.86-3.22) 1.52 (0.81-2.88)
South Africa 18/351 (5.13) 15/306 (4.90) 1.21 (0.59-2.51) 1.18 (0.58-2.38)
aControlled for cluster, site and ipw (inverse probability weights).
bControlled for cluster, site, ipw and socio-economic status.
‡p ≤ 0,001, *p < 0.05.
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lation from their respective study areas and were not
purposely selected from well-to-do families. In both arms
of the PROMISE EBF trial in Burkina Faso and Uganda,
we observed a gradual and substantial shift of the distri-
butions towards poorer linear growth with increasing age,
with a mean LAZ between −0.6 and −0.9 at 24 weeks.
This growth pattern is described also in other studies in
sub-Saharan Africa [37].
In Burkina Faso and Uganda, the prevalence of wasting
was slightly higher in the intervention arms as compared
to the control arms at 12 and 24 weeks. This finding in-
forms the debate launched by Kramer and colleagues
who also found an average weight reduction associated
with EBF, and could not rule out an increased risk of un-
dernutrition [3,5]. This could indicate that our interven-
tion was inappropriate for the most vulnerable children.
Even if the difference in mean WLZ of the children in
the intervention and the control arms in Burkina Faso
and Uganda was similar at 24 weeks, the distribution
of the WLZ of the children in the intervention arm in
Burkina Faso was skewed towards lower values, away from
the WHO growth standard mean, while in Uganda, the
mean WLZ among children in the intervention arm was
closer to the WHO WLZ mean. A shift towards lower
WLZ might benefit populations in which obesity is com-
mon [16], but in Uganda, where most communities are
challenged by widespread undernutrition, the long term
health consequences of a possible impairment in ponderal
growth could be a concern.
The one week training course equipped the peer
counsellors with basic information on promoting and
supporting EBF, thus increasing EBF prevalences sub-
stantially in Burkina Faso and Uganda [24]. However,the peer counsellors had relatively low educational level
and did not have other training in health care. Further,
they often operated in environments with limited infra-
structure with respect to water and sanitation, and where
the public health system was not optimal, accessible and
equitable, contributing to wasting, stunting and under-
weight [47]. Further research is needed to address the role
and qualifications of peer counsellors for EBF to provide
them with support to deliver safe interventions [30].
Our research group has described, particularly in
Uganda, how poverty and food insecurity is an important
challenge to proper child feeding [48,49]. This is also a
problem in Burkina Faso where the anthropometric status
of children seems to be even worse [50]. It is also known
that formula feeding is mostly unaffordable, unacceptable
and unfeasible in both Burkina Faso and Uganda [49], so
access to industry formula cannot explain any of our find-
ings. Neither can increased diarrhoea morbidity [18]. Even
if the intervention has been described as acceptable by
mothers in Uganda [51], it is not fully understood how the
intervention altered feeding behaviour. However, a recent
quantitative description from the Promise EBF trial on
changes in feeding categories at the different time points
[52] informs us that there are shifts in all directions with
time between the different feeding categories. It is import-
ant that future studies address how an infant feeding
intervention might change both maternal and infant diets
and behaviour.
Breastfeeding of infants up to 6 months of age was
nearly universal in both Burkina Faso and Uganda [53].
This intervention might mainly have shifted infants from
being predominantly or partially breastfed to being exclu-
sively breastfed [52]. However, it is important to assess
how the observed changes have impacted on morbidity
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predominant to exclusive breastfeeding up to six months
does not add any health benefits [9]. A trial in Guinea-
Bissau, despite challenges with high losses to follow-up,
saw higher EBF prevalence in the intervention arm, but
did not find a beneficial impact on diarrhoea prevalence,
mortality or infant weight [54]. In fact, in the subset (40%)
of children that were weighed close to 6 months of age,
the median weight in the intervention group was slightly
lower than in the control group. Likewise, our PROMISE
EBF trial found no effect on diarrhoea morbidity [18].
Assessment of mortality did not indicate clear differences
but were not powered for comparing the trial arms
[40,41]. Although our trial protocol did not calculate
sample size for child growth we think the sample size was
sufficient for this intention-to-treat analysis on growth
patterns. This is supported by a post hoc power calculation
indicating high power, the narrow confidence intervals
(Additional file 1) and high follow-up rates (Figure 1).
Follow-up studies are needed to assess long-term
growth and health patterns for these children in order to
balance potential negative and positive effects of EBF
promotion is these settings. This will inform WHO’s
global nutrition target towards 2025 aiming at reducing
malnutrition [55].
Conclusion
There were small differences in growth patterns between
the study arms in the three countries. In both Burkina
Faso and Uganda, children in the intervention clusters
had slightly lower ponderal growth at 24 weeks of age.
Beneficial health effects or absence of negative impact on
morbidity, mortality and infant growth reported in some
EBF promotion trials in Asia have yet to be demonstrated
in Africa. There is a need to better understand 1) the
reasons for this discrepancy, 2) how to optimize infant
feeding support in Sub-Saharan Africa, where predomin-
ant breastfeeding and undernutrition is common, and 3)
how to ensure that breastfeeding promotion can effect-
ively be combined with appropriate referral of vulnerable
children for nutritional support and disease management.
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